PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Predictive Testing to Emerge as a Key Growth Area in European Genetic Testing and Screening Services Market - Despite growing demand, varied reimbursement and regulatory policies could impede market momentum - Drugdiscovery.Frost.com
Predictive Testing to Emerge as a Key Growth Area in European Genetic Testing and Screening Services Market

 

NewswireToday - /newswire/ - London, United Kingdom, 2012/07/17 - Despite growing demand, varied reimbursement and regulatory policies could impede market momentum - Drugdiscovery.Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The European genetic testing and screening services market is poised to be driven by the increasing availability of tests covering a wider range of disease areas, paralleled by a rapidly expanding pool of potential consumers. Testing for genetic diseases has swiftly moved from the laboratory into medical practice. In this process, issues related to quality have not received adequate attention.

New analysis from Frost & Sullivan (drugdiscovery.frost.com), European Genetic Testing and Screening Services Market, finds that the market earned revenues of $896.2 million in 2011 and estimates this to reach $1908.8 million in 2018. The research covers diagnostic testing/screening, relationship testing and predictive testing. Heightened awareness, primarily due to widespread genetic counselling groups and the availability of direct-to-consumer (DTC) tests will boost market prospects.

"Demand for genetic testing will receive further impetus when accompanied by consultation, counselling physician's advice and proper reimbursement," noted Frost & Sullivan Senior Research Analyst Divyaa Ravishankar. "There is a rising interest in predictive testing, which is seen as the highest growth area within genetic testing."

Genetic testing and screening are the next big focus in molecular diagnostics. The molecular diagnostics market in Western Europe is worth $1,352.4 million, and genetic testing contributed almost 66 per cent of its revenue in 2011.

The cost of sequencing a genome is reducing, with new, efficient next-generation sequencing platforms. This will create fierce competition for faster turn-around times and will have a positive impact on the genetic testing and screening market.

Varying reimbursement procedures across Europe, however, loom as a major concern to market participants. When samples are being shipped across international boundaries, inadequate reimbursement can result in uneven access to genetic testing services.

"There are potential gaps that exist in the regulatory and normative framework which need to be addressed," cautioned Ravishankar. "Currently, there is no legal requirement on quality assurance, specifically for diagnostic laboratories in different member states of the EU."

Obtaining accreditation and certification is entirely voluntary. Only a few European labs have obtained them. Moreover, the definitions of ‘accreditation' and ‘certification' are still not universally accepted in EU member states.

"Defining a framework for reimbursement related to cross-border exchange of samples for genetic testing and data is critical," advised Ravishankar. "Proper rules should be framed for reimbursement when samples are tested in other nations; pan-European co-operation will be essential to streamlining cross-border shipping."

If you are interested in more information on this study, please send an email with your contact details to Janique Morvan, Corporate Communications, at janique.morvan[.]frost.com.

European Genetic Testing and Screening Services Market is part of the Clinical Diagnostics Growth Partnership Services programme, which also includes research in the following markets: Western European In Vitro Diagnostics (IVD) Market, European Molecular Diagnostics Market and Strategic Analysis of the European Stem Cell Research Tools Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion | Join Us: Join our community | Subscribe: Newsletter on "the next big thing" | Register: Gain access to visionary innovation.

European Genetic Testing and Screening Services Market / M7D9-55

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Predictive Testing to Emerge as a Key Growth Area in European Genetic Testing and Screening Services Market

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan |
Publisher Contact: Janique Morvan 
+33(0)1 42 81 20 37 / +33(0)6 79 22 41 42 (mobile) janique.morvan[.]frost.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration
New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians
Greenphire and Exostar Partner to Deliver Seamless, Secure Access to Clinical Research Site Payment Solution
PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions
First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Al Rowaad Advocates & Legal Consultants

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)